7,541.40

-38.67

-0.51%

51,983.98

+213.67

+0.41%

25,164.36

-272.63

-1.07%

2,805.88

-5.97

-0.21%

4.8940

-0.0350

-0.71%

21.15

+1.73

+8.91%

3,954.30

-15.30

-0.39%

76,591.80

-1,640.70

-2.10%

Crude Oil Dec 26

96.39

-0.07

-0.07%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Delayed Quote USD

Chemomab Therapeutics Ltd. (CMMB)

1.1800 +0.0200 (+1.72%)

At close: 4:00:01 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective

GlobeNewswire 10h ago

CMMB
-0.15%
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire 2mo ago

CMMB
-0.15%
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis

GlobeNewswire 3mo ago

CMMB
-0.15%
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire 5mo ago

CMMB
-0.15%
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference

GlobeNewswire 2mo ago
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire 7mo ago
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire 8mo ago

CMMB
-0.15%
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

GlobeNewswire 10mo ago

CMMB
-0.15%
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit

GlobeNewswire 11mo ago

CMMB
-0.15%

Performance Overview

Return	CMMB	MSCI WORLD (^990100-USD-STRD)
YTD	-28.05%	+9.39%
1-Year	-61.44%	--
3-Year	-59.59%	+69.90%

Mobilize your Website

View Site in Mobile | Classic

Share by: